Wyoming Pharmacies, LLC d/b/a Kentuckiana Pharmacy, Dr. Assad Nasr, and Dr. Erin Morsey v. Crosses Enterprises, LLC and Dr. Rafael Cruz (mem. dec.) ( 2017 )


Menu:
  • MEMORANDUM DECISION                                                           FILED
    09/12/2017, 10:32 am
    Pursuant to Ind. Appellate Rule 65(D),                                        CLERK
    this Memorandum Decision shall not be                                     Indiana Supreme Court
    Court of Appeals
    regarded as precedent or cited before any                                      and Tax Court
    court except for the purpose of establishing
    the defense of res judicata, collateral
    estoppel, or the law of the case.
    ATTORNEY FOR APPELLANTS                                  ATTORNEY FOR APPELLEES
    A. David Hutson                                          James F. Guilfoyle
    Hutson Legal                                             Guilfoyle Law Office
    Jeffersonville, Indiana                                  Jeffersonville, Indiana
    IN THE
    COURT OF APPEALS OF INDIANA
    Wyoming Pharmacies, LLC                                  September 12, 2017
    d/b/a Kentuckiana Pharmacy,                              Court of Appeals Case No.
    Dr. Assad Nasr, and Dr. Erin                             10A01-1703-MI-514
    Morsey,                                                  Appeal from the Clark Circuit
    Appellants-Defendants,                                   Court
    The Honorable Andrew Adams,
    v.                                               Judge
    Trial Court Cause No.
    Crosses Enterprises, LLC and                             10C01-1701-MI-6
    Dr. Rafael Cruz,
    Appellees-Plaintiffs.
    Najam, Judge.
    Court of Appeals of Indiana | Memorandum Decision 10A01-1703-MI-514 | September 12, 2017          Page 1 of 9
    Statement of the Case
    [1]   Wyoming Pharmacies, doing business as Kentuckiana Pharmacy; Dr. Assad
    Nasr; and Dr. Erin Morsey (collectively “Kentuckiana Pharmacy”) bring this
    interlocutory appeal as of right following the trial court’s issuance of a
    preliminary injunction that prohibited Kentuckiana Pharmacy from relocating
    its business pending resolution of the case. Kentuckiana Pharmacy raises one
    issue on appeal, namely, whether the trial court abused its discretion when it
    issued the preliminary injunction without providing sufficient findings of fact
    and conclusions thereon.
    [2]   We reverse and remand for further proceedings.
    Facts and Procedural History
    [3]   Dr. Rafael Cruz is a physician and the sole member of Crosses Enterprises,
    LLC (collectively “Crosses Enterprises”), which had leased office space for Dr.
    Cruz’s medical practice. Drs. Nasr and Morsey are pharmacists. On July 18,
    2014, Crosses Enterprises, through Dr. Cruz, offered Dr. Nasr the use of empty
    office space in the same building as his medical practice to use as a pharmacy.
    On July 25, Drs. Cruz, Nasr, and Morsey formed Kentuckiana Pharmacy, a
    Wyoming limited liability company, that operated out of Crosses Enterprises’
    office space. On August 4, Kentuckiana Pharmacy obtained its Certificate of
    Authority from the Indiana Secretary of State’s office.
    [4]   On November 6, the parties signed an operating agreement. Pursuant to that
    agreement, all three individuals each “own 33.3%” of Kentuckiana Pharmacy
    Court of Appeals of Indiana | Memorandum Decision 10A01-1703-MI-514 | September 12, 2017   Page 2 of 9
    and will each receive “a 33.3% share of the profits.” Appellant’s App. Vol. II at
    65. The operating agreement also provided that the members agreed to divide
    the profits “three or four times a year depending on cash flow” and that “[a]ll
    partners will have equal access to the ‘books’ and any financial information
    pertaining to the operations of all the pharmacies.” Id. The pharmacy began
    operations in June 2015.
    [5]   At the end of the year, Dr. Nasr met with his accountant to begin preparing his
    taxes. The accountant informed Dr. Nasr that Kentuckiana Pharmacy was
    registered with the IRS as a single-member limited liability company (“LLC”)
    instead of a multi-member LLC. On the advice of Dr. Nasr’s accountant, Dr.
    Nasr presented a resolution to Drs. Cruz and Morsey that would remove Drs.
    Cruz and Morsey as members of Kentuckiana Pharmacy. Drs. Nasr and
    Morsey signed the document. Dr. Cruz’s signature appears on the document
    but the parties contest whether he actually signed it.
    [6]   On July 20, 2016, Drs. Cruz and Nasr put in an offer to buy a piece of property
    for the pharmacy, but the deal did not go through. On December 26, Dr. Nasr
    individually executed a lease agreement for a new location for Kentuckiana
    Pharmacy.
    [7]   On January 12, 2017, Dr. Cruz filed a complaint in the trial court alleging
    twelve counts of wrongdoing on the part of Drs. Nasr and Morsey. On
    February 8, Dr. Cruz moved for a preliminary injunction to “maintain the status
    quo” and to prevent Dr. Nasr from relocating Kentuckiana Pharmacy out of
    Court of Appeals of Indiana | Memorandum Decision 10A01-1703-MI-514 | September 12, 2017   Page 3 of 9
    Crosses Enterprises’ office space without Dr. Cruz’s consent. Appellant’s App.
    Vol. II at 31.
    [8]   The trial court held a hearing on the motion for a preliminary injunction on
    February 22. During the hearing, Karen Sherlock appeared as a witness on
    behalf of Dr. Cruz. Sherlock is Dr. Cruz’s assistant and the custodian of his
    business records. Sherlock testified that Dr. Cruz is currently an owner of
    Kentuckiana Pharmacy and that she was not aware of any document that Dr.
    Cruz signed to relinquish his ownership interest in Kentuckiana Pharmacy.1
    She further testified that “Dr. Nasr has access to Dr. Cruz’s signature on
    prescriptions and because he has prescriptive authority to [give] vaccinations, so
    he could have lifted it off of there.” Tr. at 35. Sherlock also testified that she
    was not aware of any rent paid by Kentuckiana Pharmacy to Crosses
    Enterprises for the use of the office space.
    [9]   Dr. Nasr testified that Dr. Cruz’s only involvement with Kentuckiana
    Pharmacy involved mutual customers and that Dr. Cruz had never requested to
    see Kentuckiana Pharmacy’s books or records. Dr. Nasr further testified that
    he was present when Dr. Cruz signed the resolution removing Drs. Cruz and
    Morsey as members of Kentuckiana Pharmacy and that he witnessed Dr. Cruz
    sign the document. He also testified that he believed that the resolution made
    1
    Dr. Cruz argues in his Appellees’ brief that he was not aware of the resolution and that he did not sign it.
    Court of Appeals of Indiana | Memorandum Decision 10A01-1703-MI-514 | September 12, 2017               Page 4 of 9
    Drs. Cruz and Morsey “not members of the company” and also “not owners of
    the company.” Tr. at 86.
    [10]   On March 2, the trial court entered a preliminary injunction against
    Kentuckiana Pharmacy. The trial court’s order states:
    FINDINGS/ORDER
    Comes now the Court, having held a hearing on February 22,
    2017, and finds as follows:
    1. Wyoming Pharmacies, LLC is [a] Wyoming Corporation
    doing business in Indiana as Kentuckiana Pharmacy and
    Kentuckiana Pharmacies, and that this Court has jurisdiction
    over this matter as the primary location of operations is Clark
    County, Indiana;
    2. That Plaintiff Dr. Rafael Cruz and Defendants Dr. Assad
    Nasr and Dr. Erin Morsey formed Wyoming Pharmacies,
    LLC [on] July 21, 2014 and the parties entered into an
    agreement as Wyoming Pharmacies, LLC to do business as
    Kentuckiana Pharmacy and Kentuckiana Pharmacies that
    provided the three partners an[] equal share in the profits of
    Kentuckiana Pharmacy;
    3. That there exists a dispute over ownership of the corporation;
    4. That the Defendant is enjoined from relocating the
    corporation pending resolution of this matter;
    5. That the Plaintiff is required to post a security bond in the
    amount of $25,000 in accordance with Indiana Trial
    Procedure 65(c).
    Court of Appeals of Indiana | Memorandum Decision 10A01-1703-MI-514 | September 12, 2017   Page 5 of 9
    Appellant’s App. Vol. II at 8. This appeal ensued.
    Discussion and Decision
    [11]   Kentuckiana Pharmacy argues that the entry of the preliminary injunction was
    an abuse of discretion. Specifically, Kentuckiana Pharmacy contends that the
    trial court issued the preliminary injunction “without considering the adequacy
    of the physician’s remedies at law, his likelihood of success at trial, the balance
    of harms[,] or the public interest.” Appellant’s Br. at 4.
    [12]   “[T]he power to issue a preliminary injunction should be used sparingly, and
    such relief should not be granted except in rare instances in which the law and
    facts are clearly within the moving party’s favor.” Union Twp. School Corp. v.
    State ex rel. Joyce, 
    706 N.E.2d 183
    , 189 (Ind. Ct. App. 1998), trans denied. The
    grant or denial of a preliminary injunction rests within the sound discretion of
    the trial court, and our review is limited to whether there was a clear abuse of
    that discretion. Apple Glen Crossing, LLC v. Trademark Retail, Inc., 
    784 N.E.2d 484
    , 487 (Ind. 2003). To obtain a preliminary injunction, the moving party has
    the burden of showing by a preponderance of the evidence that: (1) the
    movant’s remedies at law are inadequate, which will cause him irreparable
    harm pending resolution of the substantive action; (2) the movant has at least a
    reasonable likelihood of success at trial by establishing a prima facie case; (3) the
    threatened injury to the movant outweighs the potential harm to the nonmoving
    party that would result from the grant of an injunction; and (4) the public
    interest would not be disserved by the injunction. 
    Id.
     If the movant fails to
    Court of Appeals of Indiana | Memorandum Decision 10A01-1703-MI-514 | September 12, 2017   Page 6 of 9
    prove any of these requirements, the trial court’s grant of an injunction is an
    abuse of discretion. 
    Id.
    [13]   Kentuckiana Pharmacy argues that the trial court committed reversible error
    because it failed to issue findings of fact and conclusions thereon pursuant to
    Indiana Trial Rule 52. Trial Rule 52 provides that “[t]he court shall make
    special findings of fact without request . . . in granting or refusing preliminary
    injunctions . . . .” Further, Trial Rule 65(D) provides that “[e]very order
    granting temporary injunction and every restraining order shall include or be
    accompanied by findings as required by Rule 52[.]” “A trial court’s failure to
    enter findings of fact and conclusions of law, as required by Ind. Trial Rule 52
    and Ind. Trial Rule 65, in an order granting a preliminary injunction constitutes
    reversible error.” GKC Indiana Theatres, Inc. v. Elk Retail Investors, LLC, 
    764 N.E.2d 647
    , 651 (Ind. Ct. App. 2002).
    [14]   In this case, the trial court’s order granting the preliminary injunction contained
    only the following language:
    1. Wyoming Pharmacies, LLC is [a] Wyoming Corporation
    doing business in Indiana as Kentuckiana Pharmacy and
    Kentuckiana Pharmacies, and that this Court has jurisdiction
    over this matter as the primary location of operations is Clark
    County, Indiana;
    2. That Plaintiff Dr. Rafael Cruz and Defendants Dr. Assad
    Nasr and Dr. Erin Morsey formed Wyoming Pharmacies,
    LLC [on] July 21, 2014 and the parties entered into an
    agreement as Wyoming Pharmacies, LLC to do business as
    Kentuckiana Pharmacy and Kentuckiana Pharmacies that
    Court of Appeals of Indiana | Memorandum Decision 10A01-1703-MI-514 | September 12, 2017   Page 7 of 9
    provided the three partners an[] equal share in the profits of
    Kentuckiana Pharmacy;
    3. That there exists a dispute over ownership of the corporation;
    4. That the Defendant is enjoined from relocating the
    corporation pending resolution of this matter;
    5. That the Plaintiff is required to post a security bond in the
    amount of $25,000 in accordance with Indiana Trial
    Procedure 65(c).
    Appellant’s App. Vol. II at 8.
    [15]   The trial court did not include any specific findings of fact as required by Trial
    Rule 52 and only provides as a conclusion that a dispute exists over the
    ownership of Kentuckiana Pharmacy. The trial court’s failure to enter the
    required findings of fact and conclusions thereon in this case requires reversal.
    [16]   Although we may review a trial court’s grant of a preliminary injunction
    notwithstanding its failure to enter the mandatory findings, we will do so “only
    when the facts are simple and uncontested, and only a question of law is
    presented for review.” Whiteco Indus., Inc. v. Nickolick, 
    549 N.E.2d 396
    , 398
    (Ind. Ct. App. 1990). We do not have such a case here. It is clear from the
    record that the facts are not uncontested. Specifically, the ownership of
    Kentuckiana Pharmacy continues to be contested and is an underlying subject
    of the case before the trial court.
    Court of Appeals of Indiana | Memorandum Decision 10A01-1703-MI-514 | September 12, 2017   Page 8 of 9
    [17]   Because the ultimate outcome of this case will be determined primarily by
    factual determinations, the absence of factual findings by the trial court leaves
    us unable to determine if Crosses Enterprises has demonstrated a likelihood that
    it will prevail on the merits. See Whiteco Idus., 
    549 N.E.2d at 399
    . We
    conclude that appellate review of the trial court’s preliminary injunction is
    precluded by the lack of proper findings, and, thus, we reverse the trial court’s
    order, dissolve the preliminary injunction, and remand for further proceedings
    not inconsistent with this opinion. See 
    id.
    [18]   Reversed and remanded.
    Kirsch, J., and Brown, J., concur.
    Court of Appeals of Indiana | Memorandum Decision 10A01-1703-MI-514 | September 12, 2017   Page 9 of 9